Dongwha Pharm.Co.Ltd (000020) - Total Assets
Based on the latest financial reports, Dongwha Pharm.Co.Ltd (000020) holds total assets worth ₩647.92 Billion KRW (≈ $439.09 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 000020 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Dongwha Pharm.Co.Ltd - Total Assets Trend (2011–2025)
This chart illustrates how Dongwha Pharm.Co.Ltd's total assets have evolved over time, based on quarterly financial data. Explore how much of Dongwha Pharm.Co.Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Dongwha Pharm.Co.Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Dongwha Pharm.Co.Ltd's total assets of ₩647.92 Billion consist of 33.9% current assets and 66.1% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 2.1% |
| Accounts Receivable | ₩83.01 Billion | 12.9% |
| Inventory | ₩97.87 Billion | 15.2% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩57.17 Billion | 8.9% |
| Goodwill | ₩24.93 Billion | 3.9% |
Asset Composition Trend (2011–2025)
This chart illustrates how Dongwha Pharm.Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Dongwha Pharm.Co.Ltd market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dongwha Pharm.Co.Ltd's current assets represent 33.9% of total assets in 2025, a decrease from 39.0% in 2011.
- Cash Position: Cash and equivalents constituted 2.1% of total assets in 2025, down from 10.4% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 1.0% in 2011.
- Asset Diversification: The largest asset category is inventory at 15.2% of total assets.
Dongwha Pharm.Co.Ltd Competitors by Total Assets
Key competitors of Dongwha Pharm.Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.69 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131
|
China | CN¥6.49 Billion |
|
Bausch Health Companies Inc
TO:BHC
|
Canada | CA$24.50 Billion |
|
Dezhan HealthCare Co Ltd
SHE:000813
|
China | CN¥4.80 Billion |
|
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
|
China | CN¥8.59 Billion |
|
Hainan Haiyao Co Ltd
SHE:000566
|
China | CN¥5.79 Billion |
|
Shanxi Zhendong Pharmaceutical
SHE:300158
|
China | CN¥4.51 Billion |
Dongwha Pharm.Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.16 | 1.74 | 3.48 |
| Quick Ratio | 0.65 | 1.08 | 2.82 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩30.89 Billion | ₩102.48 Billion | ₩162.11 Billion |
Dongwha Pharm.Co.Ltd - Advanced Valuation Insights
This section examines the relationship between Dongwha Pharm.Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.38 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 3.6% |
| Total Assets | ₩642.17 Billion |
| Market Capitalization | $95.42 Million USD |
Valuation Analysis
Below Book Valuation: The market values Dongwha Pharm.Co.Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Dongwha Pharm.Co.Ltd's assets grew by 3.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Dongwha Pharm.Co.Ltd (2011–2025)
The table below shows the annual total assets of Dongwha Pharm.Co.Ltd from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩642.17 Billion ≈ $435.19 Million |
+3.64% |
| 2024-12-31 | ₩619.63 Billion ≈ $419.92 Million |
+9.68% |
| 2023-12-31 | ₩564.97 Billion ≈ $382.87 Million |
+22.52% |
| 2022-12-31 | ₩461.14 Billion ≈ $312.51 Million |
+2.98% |
| 2021-12-31 | ₩447.80 Billion ≈ $303.47 Million |
+3.23% |
| 2020-12-31 | ₩433.81 Billion ≈ $293.99 Million |
+15.37% |
| 2019-12-31 | ₩376.03 Billion ≈ $254.83 Million |
+1.47% |
| 2018-12-31 | ₩370.60 Billion ≈ $251.15 Million |
+0.92% |
| 2017-12-31 | ₩367.23 Billion ≈ $248.86 Million |
+13.13% |
| 2016-12-31 | ₩324.60 Billion ≈ $219.98 Million |
+2.34% |
| 2015-12-31 | ₩317.19 Billion ≈ $214.95 Million |
+1.31% |
| 2014-12-31 | ₩313.07 Billion ≈ $212.17 Million |
-0.98% |
| 2013-12-31 | ₩316.17 Billion ≈ $214.26 Million |
-2.50% |
| 2012-12-31 | ₩324.28 Billion ≈ $219.76 Million |
-4.46% |
| 2011-12-31 | ₩339.43 Billion ≈ $230.03 Million |
-- |
About Dongwha Pharm.Co.Ltd
Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, d… Read more